RISIVRIX

Welcome to the Brand page for “RISIVRIX”, which is offered here for In the statement, column 2, line 1 through 4 priority claimed under sec. 44 ( d) on united kingdom application no. 22999908,filed 5-7-2002, re no. 00293134, dated 7-29-2004, expires 11-6-2012 should be deleted, and priority claimed under sec. 44 ( d ) on united kingdom application no. 2299908, filed 5-7-2012, reg. no 2299908, dated 5-7-2002, expires 5-7-2012 owner of erpn comnty tm ofc reg. no. 002923134 dated 7-29-2004, expires 11-6-2012 is inserted;vaccines for human use;.

Its status is currently believed to be active. Its class is unavailable. “RISIVRIX” is believed to be currently owned by “GLAXOSMITHKLINE BIOLOGICALS S.A.”


Owner:
GLAXOSMITHKLINE BIOLOGICALS S.A.
Owner Details
Description:
In the statement, Column 2, line 1 through 4 priority claimed under sec. 44 ( d) on united kingdom application no. 22999908,filed 5-7-2002, re no. 00293134, dated 7-29-2004, expires 11-6-2012 should be deleted, and PRIORITY CLAIMED UNDER SEC. 44 ( D ) ON UNITED KINGDOM APPLICATION NO. 2299908, FILED 5-7-2012, REG. NO 2299908, DATED 5-7-2002, EXPIRES 5-7-2012 OWNER OF ERPN COMNTY TM OFC REG. NO. 002923134 DATED 7-29-2004, EXPIRES 11-6-2012 IS INSERTED;vaccines for human use;
Categories: STATEMENT